Regeneron Pharmaceuticals (REGN) Debt Ratio (2014 - 2026)

Regeneron Pharmaceuticals (REGN) posted quarterly Debt Ratio of 0.05 for Q2 2026, down 8.33% year-over-year from 0.05 in Q2 2025, and down 2.03% quarter-over-quarter from 0.05 in Q1 2026.

Regeneron Pharmaceuticals (REGN) Debt Ratio (2014 - 2026) Analysis & Trends

Regeneron Pharmaceuticals' Debt Ratio history runs 9 years deep, the most recent figure standing at 0.05 for Q2 2026.

  • In Q2 2026, Debt Ratio fell 8.33% year-over-year to 0.05; the TTM figure through Jun 2026 stood at 0.05 (down 8.33% YoY), while the FY2025 annual figure was 0.05, down 6.83% from the prior year.
  • Debt Ratio for Q2 2026 stood at 0.05, down from 0.05 in the prior quarter.
  • The five-year high for Debt Ratio was 0.08 in Q1 2022, with the low at 0.05 in Q2 2026.
  • The 5-year median for Debt Ratio is 0.06 (2024), against an average of 0.06.
  • The sharpest annual moves came in 2022 and 2025: Debt Ratio slumped 32.5% in 2022, then dropped 5.51% in 2025.
  • Regeneron Pharmaceuticals' Debt Ratio stood at 0.07 in 2022, then declined by 11.62% to 0.06 in 2023, then dropped by 12.33% to 0.05 in 2024, then declined by 6.83% to 0.05 in 2025, then declined by 2.76% to 0.05 in 2026.
  • Business Quant data shows REGN's Debt Ratio at 0.05 in Q2 2026, 0.05 in Q1 2026, and 0.05 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.05
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.12
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.47
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.26
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 0.05
Mar 31, 2026 0.05
Dec 31, 2025 0.05
Sep 30, 2025 0.05
Jun 30, 2025 0.05
Mar 31, 2025 0.05
Dec 31, 2024 0.05
Sep 30, 2024 0.05
Jun 30, 2024 0.05
Mar 31, 2024 0.06
Dec 31, 2023 0.06
Sep 30, 2023 0.06
Jun 30, 2023 0.06
Mar 31, 2023 0.07
Dec 31, 2022 0.07
Sep 30, 2022 0.07
Jun 30, 2022 0.07
Mar 31, 2022 0.08
Dec 31, 2021 0.08
Sep 30, 2021 0.08